SE8803583D0 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- SE8803583D0 SE8803583D0 SE8803583A SE8803583A SE8803583D0 SE 8803583 D0 SE8803583 D0 SE 8803583D0 SE 8803583 A SE8803583 A SE 8803583A SE 8803583 A SE8803583 A SE 8803583A SE 8803583 D0 SE8803583 D0 SE 8803583D0
- Authority
- SE
- Sweden
- Prior art keywords
- hrs
- exposure
- acetyl cysteine
- composition
- pharmaceutical composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 3
- 229960004308 acetylcysteine Drugs 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008363 phosphate buffer Substances 0.000 abstract 2
- 210000004051 gastric juice Anatomy 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8803583A SE462779B (sv) | 1988-10-10 | 1988-10-10 | Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat |
US07/258,255 US4968506A (en) | 1988-10-10 | 1988-10-14 | Pharmaceutical dosage with core of N-acetyl cystein |
EP90850133A EP0451431A1 (en) | 1988-10-10 | 1990-04-06 | Pharmaceutical composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8803583A SE462779B (sv) | 1988-10-10 | 1988-10-10 | Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8803583D0 true SE8803583D0 (sv) | 1988-10-10 |
SE8803583L SE8803583L (sv) | 1990-04-11 |
SE462779B SE462779B (sv) | 1990-09-03 |
Family
ID=20373568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8803583A SE462779B (sv) | 1988-10-10 | 1988-10-10 | Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat |
Country Status (3)
Country | Link |
---|---|
US (1) | US4968506A (sv) |
EP (1) | EP0451431A1 (sv) |
SE (1) | SE462779B (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5350741A (en) * | 1988-07-30 | 1994-09-27 | Kanji Takada | Enteric formulations of physiologically active peptides and proteins |
US5580577A (en) * | 1990-01-11 | 1996-12-03 | Herzenberg; Leonard A. | Method of treating the symptoms of human rhinovirus infection |
DE59106133D1 (de) * | 1990-10-19 | 1995-09-07 | Spirig Ag | Feste, schnell-lösliche Arzneimittelzubereitung enthaltend S-(Carboxymethyl)-L-Cystein und/oder N-Acetylcystein. |
JP4822652B2 (ja) * | 2000-11-22 | 2011-11-24 | エンド ファーマシューティカルズ インコーポレイテッド | 粘膜炎の治療 |
US6623754B2 (en) * | 2001-05-21 | 2003-09-23 | Noveon Ip Holdings Corp. | Dosage form of N-acetyl cysteine |
US20050118261A1 (en) * | 2003-06-12 | 2005-06-02 | Oien Hal J. | Compositions and methods of administering doxepin to mucosal tissue |
WO2005021056A1 (en) * | 2003-08-21 | 2005-03-10 | Cns, Inc. | Effervescent delivery system |
DK1965787T3 (da) * | 2005-11-30 | 2013-06-03 | Endo Pharmaceuticals Inc | Behandling af xerostomi med en svovlindeholdende antioxidant |
FI20060501L (sv) * | 2006-05-22 | 2007-11-23 | Biohit Oyj | Sammansättning och förfarande för att binda acetaldehyd i magen |
US20100120776A1 (en) * | 2008-11-12 | 2010-05-13 | Hall Bioscience Corporation | Carbocysteine medical foods |
CN110292569B (zh) * | 2019-07-15 | 2021-11-02 | 广东人人康药业有限公司 | 一种乙酰半胱氨酸胶囊及其制备方法 |
CN113750052B (zh) * | 2021-10-19 | 2022-11-18 | 桂林华信制药有限公司 | 一种乙酰半胱氨酸颗粒及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4499103A (en) * | 1983-03-17 | 1985-02-12 | Merck & Co., Inc. | Benzothiazole-2-sulfonamide derivatives for the topical treatment of elevated intraocular pressure |
AU574360B2 (en) * | 1983-05-13 | 1988-07-07 | Reichert, D. | Antisnoring agent |
JPS6064912A (ja) * | 1983-09-20 | 1985-04-13 | Shiseido Co Ltd | パ−マネントウェ−ブ用剤第2剤 |
IT1170268B (it) * | 1983-12-21 | 1987-06-03 | Zambon Spa | Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi |
US4767627A (en) * | 1985-05-29 | 1988-08-30 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
CH667590A5 (it) * | 1986-07-24 | 1988-10-31 | Inpharzam Int Sa | Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. . |
SE463674B (sv) * | 1987-01-15 | 1991-01-07 | Lejus Medical Ab | Foerfarande foer behandling i fluidiserad baedd av amfotaera aminosyror och amfotaera derivat av aminosyror |
-
1988
- 1988-10-10 SE SE8803583A patent/SE462779B/sv not_active IP Right Cessation
- 1988-10-14 US US07/258,255 patent/US4968506A/en not_active Expired - Fee Related
-
1990
- 1990-04-06 EP EP90850133A patent/EP0451431A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
SE462779B (sv) | 1990-09-03 |
SE8803583L (sv) | 1990-04-11 |
EP0451431A1 (en) | 1991-10-16 |
US4968506A (en) | 1990-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8603582D0 (sv) | Komposition innehallande l-dopa | |
SE8803583D0 (sv) | Pharmaceutical composition | |
AU634833B2 (en) | Pharmaceutical compositions for treating gastrointestinal distress | |
DK158541C (da) | Orale mopidamolformer og fremgangsmaade til deres fremstilling | |
CA2339221A1 (en) | Extracts of feverfew (tanacetum parthenium) against inflammatory disorders | |
DK0473333T3 (da) | Modificeret polydextrose og fremgangsmåde til fremstilling heraf | |
DE58901401D1 (de) | Pharmazeutische zubereitung zur behandlung des diabetes mellitus. | |
DE3486235D1 (de) | Fettsäure-Zusammensetzungen. | |
DE69010162D1 (de) | Zusammensetzung zur Behandlung von Entzündung. | |
PT97785A (pt) | Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina | |
AU635074B2 (en) | S(+)-ibuprofen-l-amino acid and s(+)-ibuprofen-d-amino acid as onset hastened enhanced analgesics | |
ATE35827T1 (de) | Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen. | |
HU913010D0 (en) | Method for producing inhibitors of calcium ingestion | |
ATE203907T1 (de) | Dermatologische zubereitung zur behandlung von aktinischen keratosen | |
ATE244578T1 (de) | Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit | |
FR2585572B3 (fr) | Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse | |
BG60101B2 (bg) | Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол | |
SE8701077L (sv) | Farmaceutisk beredning | |
DK0821588T3 (da) | Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder | |
DK0612522T3 (da) | Blanding og fremgangsmåde til reduktion af risiko for hypotension | |
AU4434389A (en) | Aqueous oral pharmaceutical preparation of diclofenac | |
KR900017599A (ko) | 종양 치료용 약학 조성물 | |
BR9006746A (pt) | Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio | |
IE831597L (en) | Synergistic antihypertensive pharmaceutical composition. | |
RU94013445A (ru) | Новое соединение, лейстродуксин н, способ его получения и терапевтическая композиция |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8803583-7 Effective date: 19920510 Format of ref document f/p: F |